It is a healthcare private limited company based in Habsiguda, Telangana, India, established in 2015.
2015 | Habsiguda, Telangana, India | ActiveRenal Kidney Replacement Therapies Private Limited, a active private limited company, was established on 22 January 2015 in Habsiguda, Telangana, India. Engaging in other hospital and medical care activities within the hospital and medical care sector, it holds CIN: U85110TG2015PTC097345. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Kamala Bai Pulla (Additional Director), Hemavathi Pulla (Additional Director). Past directors included Gopu Pradeep Krishna, Shivenrao Caringula, Ganesh Narsing Pulla. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at 7-102/36, Flat #302, Sai Enclave 2Nd Lane, Srinivasa Residency, Habsiguda, Telangana, 500007.
U85110TG2015PTC097345
097345
22 January 2015
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Renal Kidney Replacement Therapies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamala Bai Pulla | Additional Director | 29 Nov 2024 | Current |
| Hemavathi Pulla | Additional Director | 20 Nov 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Jan 2019 | Past |
| Pramod Abcsdd | Additional Director | 20 Nov 2024 | Past |
| Pramod Abcsdd | Director | 29 Nov 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Renal Kidney Replacement Therapies Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 576.43% decrease in profit. The company's net worth observed a substantial decline by a decrease of 20.91%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Renal Kidney Replacement Therapies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Renal Kidney Replacement Therapies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Renal Kidney Replacement Therapies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renal Kidney Replacement Therapies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kamala Bai Pulla was appointed as a Additional Director was appointed as a Additional Director on 29 Nov 2024 & has been associated with this company since 1 year 1 month . was documented.
Progress on Hemavathi Pulla was appointed as a Additional Director was appointed as a Additional Director on 20 Nov 2024 & has been associated with this company since 1 year 1 month . was documented.
The activity Renal Kidney Replacement Therapies Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was completed.
The activity Renal Kidney Replacement Therapies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad. was completed.
Progress on Renal Kidney Replacement Therapies Private Limited was registered on 22 Jan 2015 with Roc Hyderabad & aged 10 years 11 months as per MCA records. was documented.
The CIN of Renal Kidney Replacement Therapies Private Limited is U85110TG2015PTC097345.
Renal Kidney Replacement Therapies Private Limited is headquartered at 7-102/36, Flat #302, Sai Enclave 2Nd Lane, Srinivasa Residency, Habsiguda, Telangana, 500007.
Renal Kidney Replacement Therapies Private Limited was incorporated on 22 January 2015.
The current directors of Renal Kidney Replacement Therapies Private Limited are
The primary industry of Renal Kidney Replacement Therapies Private Limited is Hospital And Medical Care.
Renal Kidney Replacement Therapies Private Limited is unlisted.
The authorized capital of Renal Kidney Replacement Therapies Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Renal Kidney Replacement Therapies Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX